BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

844 related articles for article (PubMed ID: 31832589)

  • 1. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in rectal cancer.
    Chen JN; Liu Z; Wang ZJ; Mei SW; Shen HY; Li J; Pei W; Wang Z; Wang XS; Yu J; Liu Q
    World J Gastroenterol; 2020 Jun; 26(21):2877-2888. PubMed ID: 32550762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lateral pelvic lymph node dissection after neoadjuvant chemo-radiation for preoperative enlarged lateral nodes in advanced low rectal cancer: study protocol for a randomized controlled trial.
    Wei M; Wu Q; Fan C; Li Y; Chen X; Zhou Z; Han J; Wang Z
    Trials; 2016 Nov; 17(1):561. PubMed ID: 27884204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local recurrences in western low rectal cancer patients treated with or without lateral lymph node dissection after neoadjuvant (chemo)radiotherapy: An international multi-centre comparative study.
    Kroon HM; Malakorn S; Dudi-Venkata NN; Bedrikovetski S; Liu J; Kenyon-Smith T; Bednarski BK; Ogura A; van de Velde CJH; Rutten HJT; Beets GL; Thomas ML; Kusters M; Chang GJ; Sammour T
    Eur J Surg Oncol; 2021 Sep; 47(9):2441-2449. PubMed ID: 34120810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of neoadjuvant chemoradiotherapy combined with lateral lymph nodes dissection or not on the local recurrence of low to intermediate-stage II/III rectal cancer.
    Li C; Luan J; Ji X; Wang X; Li J; Li X; Zhou Y
    J Surg Oncol; 2024 Feb; 129(2):273-283. PubMed ID: 37811551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer.
    Ogura A; Konishi T; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Beets GL; Rutten HJT; Kusters M;
    J Clin Oncol; 2019 Jan; 37(1):33-43. PubMed ID: 30403572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastases in rectal cancer after preoperative radiochemotherapy: impact of intramesorectal distribution and residual micrometastatic involvement.
    Sprenger T; Rothe H; Becker H; Beissbarth T; Homayounfar K; Gauss K; Kitz J; Wolff H; Scheel AH; Ghadimi M; Rödel C; Conradi LC; Liersch T
    Am J Surg Pathol; 2013 Aug; 37(8):1283-9. PubMed ID: 23851331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YpN0 rectal cancer patients with sterilized lymph nodes after neoadjuvant chemoradiotherapy are of greater risk of recurrence.
    Manceau G; Margot N; Augustin J; Bardier A; Simon JM; Bachet JB; Spano JP; Maingon P; Vaillant JC; Karoui M
    Dig Liver Dis; 2020 Feb; 52(2):214-220. PubMed ID: 31427089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Extranodal Extension in Rectal Cancer Patients Undergoing Radical Resection After Preoperative Chemoradiotherapy.
    Kim YI; Cho H; Kim CW; Park Y; Kim J; Ro JS; Lee JL; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2021 Mar; 20(1):e35-e42. PubMed ID: 33191166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative lateral lymph node features and impact on local recurrence after neoadjuvant chemoradiotherapy and total mesorectal excision for locally advanced rectal cancer: results from a multicentre international cohort study.
    Achilli P; Ferrari D; Calini G; Bertoglio CL; Magistro C; Origi M; Carnevali P; Alampi BD; Giusti I; Ferrari G; Calafiore E; Spinelli A; Grass F; Deslarzes P; Hahnloser D; Abdalla S; Larson DW
    Colorectal Dis; 2024 Mar; 26(3):466-475. PubMed ID: 38243617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of nodal involvement in rectal cancer after chemoradiotherapy.
    Haak HE; Beets GL; Peeters K; Nelemans PJ; Valentini V; Rödel C; Kuo L; Calvo FA; Garcia-Aguilar J; Glynne-Jones R; Pucciarelli S; Suarez J; Theodoropoulos G; Biondo S; Lambregts DMJ; Beets-Tan RGH; Maas M
    Br J Surg; 2021 Oct; 108(10):1251-1258. PubMed ID: 34240110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lateral lymph node dissection in rectal cancer: State of the art review.
    Hazen SJA; Sluckin TC; Konishi T; Kusters M
    Eur J Surg Oncol; 2022 Nov; 48(11):2315-2322. PubMed ID: 34802862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of relatively low neoadjuvant radiation doses for locally advanced rectal cancer: A propensity score-matched analysis.
    Ye W; Shi L; Qian L; Sun Y; Sun X
    Cancer Rep (Hoboken); 2019 Oct; 2(5):e1188. PubMed ID: 32721108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncologic impact of lateral lymph node metastasis at the distal lateral compartment in locally advanced low rectal cancer after neoadjuvant (chemo)radiotherapy.
    Akiyoshi T; Yamaguchi T; Hiratsuka M; Mukai T; Hiyoshi Y; Nagasaki T; Ueno M; Fukunaga Y; Konishi T
    Eur J Surg Oncol; 2021 Dec; 47(12):3157-3165. PubMed ID: 34284904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poorer Oncologic Outcome of Good Responders to PCRT With Remnant Lymph Nodes Defies the Oncologic Paradox in Patients With Rectal Cancer.
    Cho E; Park IJ; Hong SM; Lee JL; Kim CW; Yoon YS; Lim SB; Yu CS; Kim JC
    Clin Colorectal Cancer; 2019 Jun; 18(2):e171-e178. PubMed ID: 31027968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of Lateral Pelvic Lymph Node Size in Predicting Metastasis and Prognosis in Rectal Cancer.
    Lee D; Matsuda T; Yamashita K; Hasegawa H; Yamamoto M; Kanaji S; Oshikiri T; Nakamura T; Suzuki S; Fukumoto T; Kakeji Y
    Anticancer Res; 2019 Feb; 39(2):993-998. PubMed ID: 30711986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of (Chemo)Radiotherapy on Enlarged Lateral Lymph Nodes in Patients With Locally Advanced Rectal Cancer.
    van der Zijden CJ; Schreurs HWH; van den Hoek S; van Geel AM; Dekker JWT; Roos D
    Clin Colorectal Cancer; 2024 Jun; 23(2):128-134.e1. PubMed ID: 38735828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy.
    Ogura A; Konishi T; Beets GL; Cunningham C; Garcia-Aguilar J; Iversen H; Toda S; Lee IK; Lee HX; Uehara K; Lee P; Putter H; van de Velde CJH; Rutten HJT; Tuynman JB; Kusters M;
    JAMA Surg; 2019 Sep; 154(9):e192172. PubMed ID: 31268504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.